Hunan Er-Kang Pharmaceutical Co., Ltd (SHE:300267)
China · Delayed Price · Currency is CNY 4.200
+0.110 (2.69%)
Apr 29, 2026, 3:14 PM CST
SHE:300267 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | -414.32 | -399.31 | -373.37 | -195.32 | 45.94 | -791.2 |
Depreciation & Amortization | 180.95 | 180.95 | 197.36 | 204.29 | 176.49 | 197.09 |
Other Amortization | 3.45 | 3.45 | 3.45 | 7.81 | 5.28 | 2.26 |
Loss (Gain) From Sale of Assets | -0.31 | -0.31 | -0.2 | -8.8 | -0.05 | -0.23 |
Asset Writedown & Restructuring Costs | 358.8 | 358.8 | 237.41 | 12.91 | 0 | 703.18 |
Loss (Gain) From Sale of Investments | 18.17 | 18.17 | 55.58 | 8.53 | -18.88 | -18.84 |
Provision & Write-off of Bad Debts | - | - | -1.53 | 62.85 | 7.56 | -11.54 |
Other Operating Activities | 16.37 | 7.14 | 21.2 | 29.46 | 1.73 | 208.2 |
Change in Accounts Receivable | 2.48 | 2.48 | -21.89 | -19.96 | -9.11 | 125.94 |
Change in Inventory | 42.03 | 42.03 | 66.64 | 46.97 | -111.76 | -161 |
Change in Accounts Payable | 27.71 | 27.71 | -35.61 | 8.58 | 76.47 | 35.93 |
Change in Other Net Operating Assets | -12.99 | -12.99 | 15.35 | -18.47 | 133.6 | -137.98 |
Operating Cash Flow | 251.92 | 257.68 | 166.69 | 148.42 | 281.02 | 92.68 |
Operating Cash Flow Growth | 65.90% | 54.59% | 12.31% | -47.19% | 203.20% | -18.33% |
Capital Expenditures | -169.14 | -163.98 | -195.6 | -238.19 | -173.49 | -349.33 |
Sale of Property, Plant & Equipment | 1.41 | 1.74 | 0.18 | 20.11 | 0.4 | 1.24 |
Cash Acquisitions | - | - | - | - | - | -60.55 |
Divestitures | - | - | - | - | 1.42 | 3.31 |
Investment in Securities | -70 | 30 | -119.77 | 100.35 | -100 | 354.93 |
Other Investing Activities | 1.43 | 3.78 | -6.97 | 12.81 | 13.09 | 17.22 |
Investing Cash Flow | -236.3 | -128.47 | -322.15 | -104.92 | -258.58 | -33.18 |
Short-Term Debt Issued | - | - | 546.08 | 341 | 376.75 | 396 |
Long-Term Debt Issued | - | 671.34 | - | - | - | - |
Total Debt Issued | 820.34 | 671.34 | 546.08 | 341 | 376.75 | 396 |
Short-Term Debt Repaid | - | - | -401 | -380.13 | -246 | -613 |
Long-Term Debt Repaid | - | -597.7 | -5.52 | -3.36 | -5.07 | -3.32 |
Total Debt Repaid | -536 | -597.7 | -406.52 | -383.5 | -251.07 | -616.32 |
Net Debt Issued (Repaid) | 284.34 | 73.64 | 139.56 | -42.5 | 125.68 | -220.32 |
Issuance of Common Stock | 0.75 | - | - | 30.59 | - | - |
Common Dividends Paid | -11.86 | -11.09 | -8.42 | -70.1 | -4.73 | -114.92 |
Other Financing Activities | -201.53 | -94.08 | 10 | -84 | -130.33 | -0.01 |
Financing Cash Flow | 71.7 | -31.54 | 141.14 | -166.01 | -9.37 | -335.25 |
Foreign Exchange Rate Adjustments | -2.8 | -3.36 | -6.41 | 0.2 | 18.3 | -2.98 |
Net Cash Flow | 84.51 | 94.31 | -20.73 | -122.3 | 31.37 | -278.72 |
Free Cash Flow | 82.78 | 93.7 | -28.91 | -89.77 | 107.53 | -256.65 |
Free Cash Flow Margin | 7.81% | 8.04% | -2.54% | -5.03% | 5.75% | -11.48% |
Free Cash Flow Per Share | 0.04 | 0.04 | -0.01 | -0.04 | 0.05 | -0.12 |
Cash Income Tax Paid | 50.53 | 44.26 | 43.32 | 58.01 | -3.22 | 70.54 |
Levered Free Cash Flow | 149.66 | 156.73 | -14.38 | 15.77 | 36.83 | -65.62 |
Unlevered Free Cash Flow | 151.15 | 156.73 | -8.95 | 19.94 | 40.48 | -59.82 |
Change in Working Capital | 88.81 | 88.81 | 26.79 | 26.7 | 62.96 | -196.24 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.